Clinical Trials Directory

Trials / Completed

CompletedNCT02916563

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation Study

Dario Blood Glucose Monitoring System - Android Devices Altitude Evaluation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
LabStyle Innovations Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study evaluates the performance of a blood glucose monitoring system at high altitudes (approximately 10,000 feet). The performance is assessed via a reference method for glucose analysis (Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer).

Detailed description

This study will be a non-randomized study conducted to assess the accuracy and performance of the Dario Blood Glucose Monitoring System at an elevated altitude. 50 subjects will be enrolled in this study. Participation includes a 15-20 minute visit to the clinical site where they will be consented. The participant will then receive a fingerstick to obtain capillary blood used to test the performance of the BGMS and to obtain a comparative glucose measurement on the reference method, the Yellow Springs Instrument 2300 STAT Plus Glucose Analyzer.

Conditions

Interventions

TypeNameDescription
DEVICEBlood Glucose Monitoring System Altitude PerformancePerformance as assessed against a reference method at an altitude of approximately 10,000 feet.

Timeline

Start date
2016-07-01
Primary completion
2016-07-01
Completion
2016-08-01
First posted
2016-09-27
Last updated
2020-11-19
Results posted
2020-10-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02916563. Inclusion in this directory is not an endorsement.